This New Fund Offers Targeted Exposure To Junior Biotech Disruptors

There’s a new ETF on the scene with a focus on small-cap biotech companies, offering investors exposure to junior disruptors in the biotech space. For more on this new fund which, as today’s article explains, tracks an index of biotech companies operating primarily “in the genomics, DNA technology, genetic engineering and molecular biology industries”, CLICK HERE.